ArticleOncoimmunology2016

Programmed death ligand 1 as an indicator of pre-existing adaptive immune responses in human hepatocellular carcinoma.

Qian-Kun Xie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.